Whitehawk Therapeutics, Inc. — Director's Dealing 2018

Apr 25, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aerpio Pharmaceuticals, Inc. (ARPO)
CIK: 0001422142
Period of Report: 2018-04-23

Reporting Person: HOFFMAN STEPHEN J (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-23	Stock Option (Right to Buy)	$3.59	A	300000	Acquired	2028-04-23	Common Stock (300000)	Direct

Footnotes

F1: Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date.